Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
12
2022
accepted:
03
07
2023
medline:
2
8
2023
pubmed:
2
8
2023
entrez:
2
8
2023
Statut:
epublish
Résumé
The surge of the COVID-19 pandemic challenged health services globally, and in Lesotho, the HIV and tuberculosis (TB) services were similarly affected. Integrated, multi-disease diagnostic services were proposed solutions to mitigate these disruptions. We describe and evaluate the effect of an integrated, hospital-based COVID-19, TB and HIV screening and diagnostic model in two rural districts in Lesotho, during the period between December 2020 and August 2022. Adults, hospital staff, and children above 5 years attending two hospitals were pre-screened for COVID-19 and TB symptoms. After a positive pre-screening, participants were offered to enroll in a service model that included clinical evaluation, chest radiography, SARS-CoV-2, TB, and HIV testing. Participants diagnosed with COVID-19, TB, or HIV were contacted after 28 days to evaluate their health status and linkage to HIV and/or TB care services. Of the 179160 participants pre-screened, 6623(3.7%) pre-screened positive, and 4371(66%) were enrolled in this service model. Of the total 458 diagnoses, only 17 happened in children. One positive rapid antigen test for SARS-CoV-2 was found per 11 participants enrolled, one Xpert-positive TB case was diagnosed per 85 people enrolled, and 1 new HIV diagnosis was done per 182 people enrolled. Of the 321(82.9%) participants contacted after 28 days of diagnosis, 304(94.7%) reported to be healthy. Of the individuals that were newly diagnosed with HIV or TB, 18/24(75.0%) and 46/51(90.1%) started treatment within 28 days of the diagnosis. This screening and diagnostic model successfully maintained same-day, integrated COVID-19, TB, and HIV testing services, despite frequent disruptions caused by the surge of COVID-19 waves, healthcare seeking patterns, and the volatile context (social measures, travel restrictions, population lockdowns). There were positive effects in avoiding diagnostic delays and ensuring linkage to services, however, diagnostic yields for adults and children were low. To inform future preparedness plans, research will need to identify essential health interventions and how to optimize them along each phase of the emergency response.
Identifiants
pubmed: 37531333
doi: 10.1371/journal.pgph.0001488
pii: PGPH-D-22-02010
pmc: PMC10395971
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0001488Informations de copyright
Copyright: © 2023 Katende et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Med. 2022 Mar 11;3(3):162-166
pubmed: 35169763
Public Health Pract (Oxf). 2021 Nov;2:100198
pubmed: 34632434
J Int AIDS Soc. 2018 Jan;21(1):
pubmed: 29381257
Microbiol Spectr. 2022 Aug 31;10(4):e0085322
pubmed: 35938792
Sci Rep. 2020 Feb 5;10(1):1917
pubmed: 32024860
Nat Med. 2022 Jun;28(6):1314-1324
pubmed: 35288697
Curr HIV/AIDS Rep. 2022 Feb;19(1):26-36
pubmed: 34982406
Lancet Digit Health. 2021 Sep;3(9):e543-e554
pubmed: 34446265
BMJ Open. 2021 Mar 16;11(3):e045343
pubmed: 33727273
PLoS One. 2023 Mar 2;18(3):e0278653
pubmed: 36862684
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34853031
Int J Environ Res Public Health. 2022 Sep 21;19(19):
pubmed: 36231201
Implement Sci Commun. 2023 Jan 17;4(1):8
pubmed: 36650596
Lancet Glob Health. 2022 Apr;10(4):e465-e466
pubmed: 35122718
BMJ Open. 2022 Feb 8;12(2):e053290
pubmed: 35135769
Trans R Soc Trop Med Hyg. 2016 May;110(5):305-11
pubmed: 27198215
Front Med (Lausanne). 2022 Sep 06;9:969640
pubmed: 36148453
Clin Infect Dis. 2020 Jul 28;71(15):875-878
pubmed: 32227121
Trop Med Infect Dis. 2022 Jan 15;7(1):
pubmed: 35051128
Risk Manag Healthc Policy. 2021 Feb 15;14:575-584
pubmed: 33623448
Public Health Action. 2021 Dec 21;11(4):180-185
pubmed: 34956845
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
Trop Med Infect Dis. 2022 Sep 05;7(9):
pubmed: 36136639
PLoS One. 2022 Jul 28;17(7):e0271431
pubmed: 35901094
Front Public Health. 2022 Jul 22;10:921596
pubmed: 35942259
IJID Reg. 2022 Aug 30;5:33-38
pubmed: 36158597